ProfileGDS5822 / ILMN_1229210
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 74% 78% 80% 70% 82% 70% 74% 85% 89% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 17274
GSM1276600PDAC Late Ablation Control 2118.978
GSM1276601PDAC Late Ablation Control 3203.380
GSM1276602PDAC Late Ablation 146.370
GSM1276603PDAC Late Ablation 2186.782
GSM1276604PDAC Late Ablation 361.270
GSM1303940PDAC Late Ablation_anti-CTLA4 168.274
GSM1303941PDAC Late Ablation_anti-CTLA4 2326.685
GSM1303942PDAC Late Ablation_anti-CTLA4 3500.689